A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
Clinical trial NCT05014139 · TERMINATED
Trial details
- NCT number
- NCT05014139
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2025-09-22
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.